Trials / Conditions / Recurrent Gray-Zone Lymphoma
Recurrent Gray-Zone Lymphoma
3 registered clinical trials studyying Recurrent Gray-Zone Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lym NCT05507541 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma NCT02568553 | National Cancer Institute (NCI) | Phase 1 |